Discovery Lens
C Combination Innovation
Two separate worlds finally connect — and the intersection is a product
One-Liner
Hospital pharmacy controlled-substance diversion detection methodology applied to AI agent permission and access scope auditing.
AI Thinking Process
Hospital pharmacy drug-diversion detection: statistical anomaly detection on controlled substance dispensing patterns against expected wastage, cross-referenced to patient charts. Verb Transplant: apply the same behavioral-anomaly-versus-expected-use methodology to AI agent permission scope — detecting when agents are operating outside their intended authorization envelope.
Feature gate check: CrowdStrike shipped MCP server posture telemetry in April 2026 — exactly this surface. Wiz has AI security posture roadmap announced. Snyk launched AI code security features. Palo Alto Networks Cortex XSIAM covers AI workload monitoring. HIPAA hospital AI pivot: Wiz, Vanta, AWS Security Hub already present. Third consecutive AI agent infrastructure kill this session.
KILLED: positional kill, feature gate fires. AI agent infrastructure destination confirmed structurally saturated. Three consecutive kills (T2, T7, T10) within one session — codification candidate as new gene: avoid AI agent infrastructure as Verb Transplant destination during funding-wave saturation periods.
Kill Reason
CrowdStrike shipped MCP server posture telemetry in April 2026. Wiz, Snyk, and Palo Alto Networks all have AI agent posture roadmaps. Third consecutive AI agent infrastructure Verb Transplant kill this session.
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Passive voice-based depression detection requires FDA Software as a Medical Device clearance for any diagnostic claim; a "wellness" framing undercuts the core value proposition and reduces willingness to pay. Epic Systems and large telehealth platforms are already integrating validated mental health screening tools into clinical workflows, crowding out standalone apps before they achieve scale.
killed: Google Nest Hub's built-in Soli radar-based sleep sensing already delivers contactless respiratory monitoring in millions of households, and Withings has shipped FDA-cleared sleep apnea screening hardware. A standalone $30 WiFi module cannot match the distribution, brand trust, or regulatory standing of these well-resourced incumbents.
killed: Urine and stool analysis for glucose monitoring, cancer screening, and kidney function markers falls squarely into FDA Class II/III medical device territory, requiring clinical trials and 510(k) or PMA approval costing millions and taking years. The entire high-value use case — the reason anyone would buy this — is legally undeliverable without regulatory clearance the product cannot realistically obtain.